Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
1999 1
2001 1
2006 2
2008 1
2012 1
2014 1
2017 2
2018 2
2019 2
2020 3
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.
Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim DW, Ou SI, Pérol M, Dziadziuszko R, Rosell R, Zeaiter A, Mitry E, Golding S, Balas B, Noe J, Morcos PN, Mok T; ALEX Trial Investigators. Peters S, et al. N Engl J Med. 2017 Aug 31;377(9):829-838. doi: 10.1056/NEJMoa1704795. Epub 2017 Jun 6. N Engl J Med. 2017. PMID: 28586279 Free article. Clinical Trial.
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors.
Eads JR, Reidy-Lagunes D, Soares HP, Chan JA, Anthony LB, Halfdanarson TR, Naraev BG, Wolin EM, Halperin DM, Li D, Pommier RF, Zacks JS, Morse MA, Metz DC; from the Carcinoid Syndrome Control Collaborative. Eads JR, et al. Among authors: naraev bg. Pancreas. 2020 Oct;49(9):1123-1130. doi: 10.1097/MPA.0000000000001658. Pancreas. 2020. PMID: 32991344 Review.
Patient Travel Concerns After Treatment with 177Lu-DOTATATE.
Kendi AT, Mailman JA, Naraev BG, Mercer DJ, Underwood JK, Halfdanarson TR. Kendi AT, et al. Among authors: naraev bg. J Nucl Med. 2020 Apr;61(4):496-497. doi: 10.2967/jnumed.120.243238. Epub 2020 Mar 13. J Nucl Med. 2020. PMID: 32169915 Free article. No abstract available.
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.
Kakadia S, Yarlagadda N, Awad R, Kundranda M, Niu J, Naraev B, Mina L, Dragovich T, Gimbel M, Mahmoud F. Kakadia S, et al. Among authors: naraev b. Onco Targets Ther. 2018 Oct 17;11:7095-7107. doi: 10.2147/OTT.S182721. eCollection 2018. Onco Targets Ther. 2018. PMID: 30410366 Free PMC article. Review.
22 results